Clinical Trials Browser

Phase 1 × disitamab vedotin × Clear all

NCT05940896 2023-11-27

RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06078982 2023-10-12

Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer

Phase 1 Unknown

Gastrointestinal

Stomach Neoplasms